Go offline with the Player FM app!
Startups, philanthropy, billionaires, academia, neuromodulation, psychedelics, AI and new therapies in bipolar, autism, and Parkinson’s with Rob Malenka
Manage episode 508062368 series 2738732
Matias interviews Rob Malenka, Chief Scientific Officer of Bayshore, the family office of Google co-founder Sergey Brin. Bayshore has played a major role in advancing treatments for Parkinson's, bipolar, and autism.
In this episode, we discuss:
- Why progress in psychiatry is slow because the brain is the most complex organ and many disorders are highly heterogeneous
- The bottlenecks including weak replicability in research, academic politics, perverse incentives, and pharma’s avoidance of neuropsychiatry
- How breakthroughs require early detection, rigorous science, and bridging academia with biotech through venture philanthropy
- How success depends on mission-driven, ethical people who align science, capital, and patient impact.
- The opportunities in neuromodulation, data-driven precision medicine, and combination therapies.
Credits:
Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky
Produced by Caitlin Ner & Nico V. Rey
Find us at businesstrip.fm and psymed.ventures
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank
63 episodes
Manage episode 508062368 series 2738732
Matias interviews Rob Malenka, Chief Scientific Officer of Bayshore, the family office of Google co-founder Sergey Brin. Bayshore has played a major role in advancing treatments for Parkinson's, bipolar, and autism.
In this episode, we discuss:
- Why progress in psychiatry is slow because the brain is the most complex organ and many disorders are highly heterogeneous
- The bottlenecks including weak replicability in research, academic politics, perverse incentives, and pharma’s avoidance of neuropsychiatry
- How breakthroughs require early detection, rigorous science, and bridging academia with biotech through venture philanthropy
- How success depends on mission-driven, ethical people who align science, capital, and patient impact.
- The opportunities in neuromodulation, data-driven precision medicine, and combination therapies.
Credits:
Created by Greg Kubin and Matias Serebrinsky
Host: Matias Serebrinsky
Produced by Caitlin Ner & Nico V. Rey
Find us at businesstrip.fm and psymed.ventures
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional Music: Distant Daze by Zack Frank
63 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.